Even though the latest experimental treatments have not produced new drugs, they have helped researchers learn more about the brain and the disease, Snyder said. Scientists are beginning to understand that a person's brain begins to change about a decade before being diagnosed with Alzheimer's disease.
"We make every effort to ensure that no stone is at stake and that all roads are taken." Said Snyder. "We are optimistic that our knowledge of science continues to grow and progress, and our ability to synthesize both the different biologies and the combination of some of them is growing."
The Borghoffs convened a family reunion on Thursday. Jeff, as always positive, said he wanted to do another clinical study in which he could enroll, so he can help scientists find a treatment or cure that could help their children or grandchildren.
Kim wants him to try medicinal marijuana or CBD oil. She hopes these options can suppress the fear and anger that Jeff is increasingly experiencing. However, they have not been approved by the FDA for the treatment or treatment of Alzheimer's or other dementias, nor have they been evaluated in clinical trials. It is also unclear how people with dementia would respond to the psychoactive effects of marijuana or how it would interact with the other drugs used to treat the disease.
"I'm still exploring all possibilities and angles, assuming that a box has six pages and I can only see three pages at a time," Jeff Borghoff said. "There are other perspectives and other things to consider."